Prostate cancer treatment that helped Jeremy Clarkson and Lord David Cameron as effective as radiotherapy
Key Points:
- A study from Imperial College London found that focal therapy, a minimally invasive prostate cancer treatment used by Jeremy Clarkson and Lord David Cameron, is as effective as traditional radiotherapy and surgery but with significantly fewer side effects.
- Focal therapy targets only the cancerous tissue within the prostate, resulting in a five-fold lower risk of side effects such as urinary incontinence and erectile dysfunction compared to conventional treatments.
- Over a decade, only 2 out of nearly 3,500 men treated with focal therapy died from prostate cancer, with cancer spread rates comparable to surgery or radiotherapy outcomes.
- The treatment is suitable for 50-66% of localized prostate cancer cases in the UK, potentially benefiting around 15,000 men annually, though currently only about 1,000 receive it due to limited awareness and access.
- The UK Government recently announced additional funding to expand focal therapy availability, supported by researchers who emphasize its excellent long-term cancer control and call for more treatment centers.